ILLUMINA INC (ILU.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:ILU - US4523271090 - Common Stock
128.44 EUR
+4.6 (+3.71%)
Overall ILU gets a fundamental rating of 6 out of 10. We evaluated ILU against 20 industry peers in the Life Sciences Tools & Services industry. ILU scores excellent points on both the profitability and health parts. This is a solid base for a good stock. ILU has a decent growth rate and is not valued too expensively. These ratings could make ILU a good candidate for quality investing.
1. Profitability
1.1 Basic Checks
- In the past year ILU was profitable.
- ILU had a positive operating cash flow in the past year.
- In multiple years ILU reported negative net income over the last 5 years.
- In the past 5 years ILU always reported a positive cash flow from operatings.
1.2 Ratios
- ILU's Return On Assets of 11.38% is amongst the best of the industry. ILU outperforms 95.00% of its industry peers.
- ILU has a Return On Equity of 29.53%. This is amongst the best in the industry. ILU outperforms 100.00% of its industry peers.
- ILU's Return On Invested Capital of 14.61% is amongst the best of the industry. ILU outperforms 95.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.38% | ||
| ROE | 29.53% | ||
| ROIC | 14.61% |
ROA(3y)-22.28%
ROA(5y)-10.63%
ROE(3y)-46.16%
ROE(5y)-23.48%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- Looking at the Profit Margin, with a value of 16.39%, ILU belongs to the top of the industry, outperforming 90.00% of the companies in the same industry.
- ILU has a better Operating Margin (20.41%) than 90.00% of its industry peers.
- In the last couple of years the Operating Margin of ILU has declined.
- ILU has a better Gross Margin (66.74%) than 100.00% of its industry peers.
- In the last couple of years the Gross Margin of ILU has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 20.41% | ||
| PM (TTM) | 16.39% | ||
| GM | 66.74% |
OM growth 3YN/A
OM growth 5Y-11.47%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.07%
GM growth 5Y-1.23%
2. Health
2.1 Basic Checks
- ILU has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
- Compared to 1 year ago, ILU has about the same amount of shares outstanding.
- ILU has more shares outstanding than it did 5 years ago.
- The debt/assets ratio for ILU is higher compared to a year ago.
2.2 Solvency
- ILU has an Altman-Z score of 4.80. This indicates that ILU is financially healthy and has little risk of bankruptcy at the moment.
- ILU has a Altman-Z score of 4.80. This is amongst the best in the industry. ILU outperforms 85.00% of its industry peers.
- The Debt to FCF ratio of ILU is 1.99, which is an excellent value as it means it would take ILU, only 1.99 years of fcf income to pay off all of its debts.
- ILU has a Debt to FCF ratio of 1.99. This is amongst the best in the industry. ILU outperforms 100.00% of its industry peers.
- A Debt/Equity ratio of 0.42 indicates that ILU is not too dependend on debt financing.
- ILU's Debt to Equity ratio of 0.42 is fine compared to the rest of the industry. ILU outperforms 80.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.42 | ||
| Debt/FCF | 1.99 | ||
| Altman-Z | 4.8 |
ROIC/WACC1.34
WACC10.88%
2.3 Liquidity
- ILU has a Current Ratio of 1.43. This is a normal value and indicates that ILU is financially healthy and should not expect problems in meeting its short term obligations.
- ILU's Current ratio of 1.43 is in line compared to the rest of the industry. ILU outperforms 50.00% of its industry peers.
- A Quick Ratio of 1.12 indicates that ILU should not have too much problems paying its short term obligations.
- ILU has a better Quick ratio (1.12) than 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.43 | ||
| Quick Ratio | 1.12 |
3. Growth
3.1 Past
- ILU shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 152.02%, which is quite impressive.
- Measured over the past years, ILU shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -17.93% on average per year.
- Looking at the last year, ILU shows a decrease in Revenue. The Revenue has decreased by -2.32% in the last year.
- ILU shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.29% yearly.
EPS 1Y (TTM)152.02%
EPS 3Y-25.65%
EPS 5Y-17.93%
EPS Q2Q%17.54%
Revenue 1Y (TTM)-2.32%
Revenue growth 3Y-1.15%
Revenue growth 5Y4.29%
Sales Q2Q%0.37%
3.2 Future
- ILU is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.95% yearly.
- ILU is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.99% yearly.
EPS Next Y96.03%
EPS Next 2Y44.64%
EPS Next 3Y34.05%
EPS Next 5Y24.95%
Revenue Next Year-0.88%
Revenue Next 2Y0.73%
Revenue Next 3Y2.34%
Revenue Next 5Y3.99%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 34.62, the valuation of ILU can be described as expensive.
- ILU's Price/Earnings ratio is a bit more expensive when compared to the industry. ILU is more expensive than 65.00% of the companies in the same industry.
- ILU's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.32.
- With a Price/Forward Earnings ratio of 29.42, ILU can be considered very expensive at the moment.
- ILU's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. ILU is more expensive than 65.00% of the companies in the same industry.
- Compared to an average S&P500 Price/Forward Earnings ratio of 24.30, ILU is valued a bit more expensive.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.62 | ||
| Fwd PE | 29.42 |
4.2 Price Multiples
- The rest of the industry has a similar Enterprise Value to EBITDA ratio as ILU.
- 80.00% of the companies in the same industry are more expensive than ILU, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 23.04 | ||
| EV/EBITDA | 20.46 |
4.3 Compensation for Growth
- ILU's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- The decent profitability rating of ILU may justify a higher PE ratio.
- A more expensive valuation may be justified as ILU's earnings are expected to grow with 34.05% in the coming years.
PEG (NY)0.36
PEG (5Y)N/A
EPS Next 2Y44.64%
EPS Next 3Y34.05%
5. Dividend
5.1 Amount
- No dividends for ILU!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
FRA:ILU (1/21/2026, 7:00:00 PM)
128.44
+4.6 (+3.71%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)10-30 2025-10-30/amc
Earnings (Next)02-05 2026-02-05/amc
Inst Owners104.7%
Inst Owner ChangeN/A
Ins Owners0.17%
Ins Owner ChangeN/A
Market Cap19.63B
Revenue(TTM)4.29B
Net Income(TTM)703.00M
Analysts73.33
Price Target111.36 (-13.3%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.9%
Min EPS beat(2)12.52%
Max EPS beat(2)15.27%
EPS beat(4)3
Avg EPS beat(4)5.34%
Min EPS beat(4)-7.76%
Max EPS beat(4)15.27%
EPS beat(8)6
Avg EPS beat(8)97.15%
EPS beat(12)10
Avg EPS beat(12)231.96%
EPS beat(16)13
Avg EPS beat(16)178.01%
Revenue beat(2)0
Avg Revenue beat(2)-0.74%
Min Revenue beat(2)-1.21%
Max Revenue beat(2)-0.28%
Revenue beat(4)0
Avg Revenue beat(4)-0.66%
Min Revenue beat(4)-1.21%
Max Revenue beat(4)-0.18%
Revenue beat(8)3
Avg Revenue beat(8)-0.29%
Revenue beat(12)4
Avg Revenue beat(12)-0.57%
Revenue beat(16)5
Avg Revenue beat(16)-0.78%
PT rev (1m)5.42%
PT rev (3m)13.87%
EPS NQ rev (1m)-0.24%
EPS NQ rev (3m)3.5%
EPS NY rev (1m)-0.01%
EPS NY rev (3m)4.26%
Revenue NQ rev (1m)-0.18%
Revenue NQ rev (3m)0.54%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)0.53%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.62 | ||
| Fwd PE | 29.42 | ||
| P/S | 5.37 | ||
| P/FCF | 23.04 | ||
| P/OCF | 20.53 | ||
| P/B | 9.68 | ||
| P/tB | 22.09 | ||
| EV/EBITDA | 20.46 |
EPS(TTM)3.71
EY2.89%
EPS(NY)4.37
Fwd EY3.4%
FCF(TTM)5.58
FCFY4.34%
OCF(TTM)6.26
OCFY4.87%
SpS23.91
BVpS13.27
TBVpS5.81
PEG (NY)0.36
PEG (5Y)N/A
Graham Number33.29
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.38% | ||
| ROE | 29.53% | ||
| ROCE | 20.76% | ||
| ROIC | 14.61% | ||
| ROICexc | 20.97% | ||
| ROICexgc | 38.52% | ||
| OM | 20.41% | ||
| PM (TTM) | 16.39% | ||
| GM | 66.74% | ||
| FCFM | 23.32% |
ROA(3y)-22.28%
ROA(5y)-10.63%
ROE(3y)-46.16%
ROE(5y)-23.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-6.48%
ROICexc growth 3YN/A
ROICexc growth 5Y-9.28%
OM growth 3YN/A
OM growth 5Y-11.47%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.07%
GM growth 5Y-1.23%
F-Score7
Asset Turnover0.69
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.42 | ||
| Debt/FCF | 1.99 | ||
| Debt/EBITDA | 0.86 | ||
| Cap/Depr | 44.36% | ||
| Cap/Sales | 2.85% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 97.57% | ||
| Profit Quality | 142.25% | ||
| Current Ratio | 1.43 | ||
| Quick Ratio | 1.12 | ||
| Altman-Z | 4.8 |
F-Score7
WACC10.88%
ROIC/WACC1.34
Cap/Depr(3y)66.6%
Cap/Depr(5y)76.75%
Cap/Sales(3y)5.82%
Cap/Sales(5y)5.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)152.02%
EPS 3Y-25.65%
EPS 5Y-17.93%
EPS Q2Q%17.54%
EPS Next Y96.03%
EPS Next 2Y44.64%
EPS Next 3Y34.05%
EPS Next 5Y24.95%
Revenue 1Y (TTM)-2.32%
Revenue growth 3Y-1.15%
Revenue growth 5Y4.29%
Sales Q2Q%0.37%
Revenue Next Year-0.88%
Revenue Next 2Y0.73%
Revenue Next 3Y2.34%
Revenue Next 5Y3.99%
EBIT growth 1Y154.36%
EBIT growth 3YN/A
EBIT growth 5Y-7.67%
EBIT Next Year36.79%
EBIT Next 3Y17.14%
EBIT Next 5Y16.22%
FCF growth 1Y495.24%
FCF growth 3Y28.14%
FCF growth 5Y-3.38%
OCF growth 1Y179.8%
OCF growth 3Y15.37%
OCF growth 5Y-4.45%
ILLUMINA INC / ILU.DE FAQ
What is the ChartMill fundamental rating of ILLUMINA INC (ILU.DE) stock?
ChartMill assigns a fundamental rating of 6 / 10 to ILU.DE.
What is the valuation status for ILU stock?
ChartMill assigns a valuation rating of 4 / 10 to ILLUMINA INC (ILU.DE). This can be considered as Fairly Valued.
How profitable is ILLUMINA INC (ILU.DE) stock?
ILLUMINA INC (ILU.DE) has a profitability rating of 7 / 10.
Can you provide the financial health for ILU stock?
The financial health rating of ILLUMINA INC (ILU.DE) is 7 / 10.